Chi-Med × Revenue and Competitors

Location

Total Funding

Industry

Estimated Revenue & Valuation

Name	Title	Email/Phone
1 Cher Sparrow	Senior Manager, Equity and Payroll	Reveal Email/Phone

Competitor Name	Revenue	Number of Employees	Employee Growth	Total Funding	Valuation
#1 Dermavant Scien...	$99.4M	458	40%	N/A	N/A
#2 Metrum Research...	$20.6M	133	22%	N/A	N/A
#3 Clovis Oncology	$156.1M	146	-70%	$145M	N/A
#4 ArcherDX	$3.5M	45	-25%	$150M	N/A
#5 Inscripta	$1.6M	21	0%	$459.5M	N/A
#6 Cerapedics	$67.3M	310	16%	$180.7M	N/A
#7 Stone Clinical ...	$8.5M	55	-2%	N/A	N/A
#8 Apellis Pharmac...	$256.3M	1025	9%	$168.5M	N/A
#9 CreoSalus	$2.8M	18	-33%	N/A	N/A
#10 MSBiotec	$9.1M	59	-9%	N/A	N/A

keywords:N/A

N/A

Total Funding

1015

Number of Employees

$157.3M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Cantlay then chimed in: I think it was 63." Cantlay was correct. On that fall day, Cantlay carded eight birdies as part of an 8-under 63...

Then it blew up and went everywhere -- t-shirts, pregame, everything, Sabonis chimed in. Sacramento sent Tyrese Haliburton,...

For example, AstraZeneca penned an agreement with HUTCHMED (formerly known as Chi-Med) for its cancer therapeutic savolitinib.

Company Name	Revenue	Number of Employees	Employee Growth	Total Funding
#1 TUV SUD	$312.6M	1015	6%	N/A
#2 Gallup-McKinley...	$255.8M	1015	2%	N/A
#3 Key Equipment F...	$184.9M	1016	-2%	N/A
#4 Yuba College	$256.5M	1018	N/A	N/A
#5 CDW-G	$206.7M	1018	1%	N/A